logo

For the Inventor, By the Inventor

Barcelona, Spain

Monica Garcia-Lopez

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:

goldMedal5 out of 150 
 
Laboratorios Del Dr. Esteve S.a.
 patents
silverMedal5 out of 33 
 
Esteve Pharmaceuticals, S.a.
 patents

Years Active: 2012-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12479830 - Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against pain (2025-11-25),
2. 10807970 - Tetrahydropyran and thiopyran derivatives having multimodal activity against pain (2020-10-20),
3. 10745361 - Piperazine derivatives having multimodal activity against pain (2020-08-18),
4. 10428051 - Substituted amide derivatives having multimodal activity against pain (2019-10-01),
5. 10351549 - Amide derivatives having multimodal activity against pain (2019-07-16),
6. 10189828 - 1-methylpyrazole-piperazine compounds having multimodal activity against pain (2019-01-29),
7. 10071968 - Methyl-1H-pyrazole alkylamine compounds having multimodal activity against pain (2018-09-11),
8. 8236845 - Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments (2012-08-07),
9. 8232307 - Indane-amine derivatives, their preparation and use as medicaments (2012-07-31),
10. 8097641 - Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-HT7 receptor ligands (2012-01-17),

Title: The Innovative Journey of Monica Garcia-Lopez

Introduction

Monica Garcia-Lopez, based in Barcelona, Spain, is an accomplished inventor with a remarkable portfolio of nine patents. Her work primarily focuses on developing compounds with multimodal activity against pain, highlighting her significant contributions to pharmacology and therapeutics.

Latest Patents

Monica's latest patents include innovative compounds that provide dual pharmacological activity. One of her notable inventions is related to tetrahydropyran and thiopyran derivatives, which exhibit activity towards both the sigma (σ) receptor and the μ-opioid receptor. This invention not only covers the processes for preparing these compounds but also details their pharmaceutical compositions and their therapeutic applications, particularly for pain management.

Another significant patent involves piperazine derivatives that also present multimodal activity against pain, targeting the same receptors. Monica's research in this area underscores the potential of these compounds in developing effective treatments for pain, a critical area in the field of medicine.

Career Highlights

Throughout her career, Monica has played pivotal roles in renowned organizations such as Laboratorios del Dr. Esteve and Esteve Pharmaceuticals. Her expertise in pharmaceutical development has been instrumental in bringing innovative treatments to the market, particularly in pain management.

Collaborations

Monica has collaborated with esteemed colleagues, including Carmen Almansa-Rosales and Antonio Torrens-Jover. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research, further enhancing her contributions to the field.

Conclusion

Monica Garcia-Lopez exemplifies the spirit of innovation in the pharmaceutical industry. With her nine patents and ongoing research, she continues to pave the way for novel therapies that address pain, improving the quality of life for countless individuals. Her work is a testament to the impact that dedicated inventors can have on improving healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…